Breaking news
MARKET REPORT: Novacyt in demand after it launches products that can detect new variants of the Covid virus By Francesca Washtell For The Daily Mail Published: 22:53 GMT, 2 February 2021 | Updated: 22:53 GMT, 2 February 2021 Novacyt proved it is still a fast mover in the battle to beat Covid after launching products … Read more
Covid test maker Novacyt saw sales rise 20-fold during the pandemic prompting its share price to rise 5,000% in a year Annual profits expected to jump from £1.6m to £91.8m in fresh results AIM-listed group’s share price has rocketed, but closed down 17% on Friday By City & Finance Reporter for the Daily Mail and … Read more
Being a fast mover in the battle to beat Covid has paid off for Novacyt, a biotechnology tiddler listed on AIM that few retail investors had heard of at the start of the year. Things have changed dramatically since then, after the French group’s Southampton-based subsidiary, Primerdesign, developed one of the world’s first coronavirus tests … Read more
Covid testing kits fuel sales boom at Novacyt as it racks up revenues of more than £90m By Daily Mail City & Finance Reporter Published: 21:50 BST, 14 May 2020 | Updated: 21:50 BST, 14 May 2020 A British producer of coronavirus testing kits expects ‘significant demand’ to continue for the rest of the year … Read more
AIM-listed biotechnology firm Novacyt shoots to stock market stardom after developing diagnostic test for Covid-19 By Daily Mail City & Finance Reporter Published: 21:50 BST, 17 April 2020 | Updated: 22:15 BST, 17 April 2020 Few amateur traders had heard of Novacyt at the start of the year. But the AIM-listed biotechnology firm has shot … Read more
Biotech minnow Novacyt up 18% after government orders thousands of coronavirus tests in a £1m deal By Daily Mail City & Finance Reporter Published: 22:15 GMT, 16 March 2020 | Updated: 20:16 GMT, 17 March 2020 Novacyt raced 18 per cent higher after Public Health England ordered thousands of its coronavirus tests in a £1million … Read more
Biotech minnow Novacyt up 18% after government orders thousands of coronavirus tests in a £3.7m deal By Daily Mail City & Finance Reporter Published: 22:15 GMT, 16 March 2020 | Updated: 22:15 GMT, 16 March 2020 Novacyt raced 18 per cent higher after Public Health England ordered thousands of its coronavirus tests in a £3.7million … Read more
Novacyt was one of the rare risers in a bloodbath week for the UK stock market, thanks to the success of its coronavirus diagnostic test which it handily launched a few weeks ago. The stock has been rising steadily for the past month or so, but shot up 33 per cent to 140.14p in the … Read more
Investors snapped up shares in biotechnology minnow Novacyt as the coronavirus edged closer to becoming a pandemic. AIM-listed Novacyt is selling a test for the infection that delivers a result in two hours and doesn’t need a doctor to oversee it. It was the first company to receive an approval for a Covid-19 test, meaning … Read more
Shares in biotechnology firm Novacyt rocket to record high after it launches test for coronavirus By Daily Mail City & Finance Reporter Published: 21:50 GMT, 17 February 2020 | Updated: 21:50 GMT, 17 February 2020 Shares in biotechnology firm Novacyt rocketed to a record high after it launched a test for the coronavirus. The AIM-listed … Read more